STUDIES OF CENTRAL NERVOUS SYSTEM FUNCTIONAL ANATOMY
中枢神经系统功能解剖学研究
基本信息
- 批准号:3845197
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Cannabis antidepressants autoradiography brain mapping cannabinoids cocaine corticosteroid receptors corticotropin releasing factor dopamine drug receptors enzyme biosynthesis human tissue in situ hybridization mood disorders neuroendocrine system neuropeptides neurotransmitter receptor psychosis stress
项目摘要
This Section combines molecular and neuroanatomical methods to reveal
dynamic CNS events that relate to issues of mental health and drug abuse.
Mapping drug and neuro-transmitter receptors using autoradiography has
provided important basic information about brain organization and
function. The cannabinoid receptor has been localized to specific
neuronal elements in brain, and we examined its relationship to the
dopamine system and to "reward" pathways. In situ hybridization
histochemistry is used to examine the regulation of gene expression of
neuropeptides, monoamine transporters and synthe-sizing enzymes, and
adrenal steroid receptors. Studies are designed to elucidate brain
mechanisms involved in stress and chronic antidepressant drug treatment,
with a focus on the role of corticotropin releasing hormone in the
pathophysiology of affective disorders. Other studies examine CNS
adaptive changes caused by drugs of abuse, such as marijuana and cocaine.
本节结合分子和神经解剖学方法,揭示
与精神健康和药物滥用问题相关的动态CNS事件。
利用放射自显影术绘制药物和神经递质受体,
提供了关于大脑组织的重要基本信息,
功能 大麻素受体定位于特定的
神经元元素在大脑中,我们研究了它的关系,
多巴胺系统和“奖励”途径。 原位杂交
组织化学用于检查基因表达的调节,
神经肽、单胺转运蛋白和合成酶,以及
肾上腺类固醇受体 研究旨在阐明大脑
参与应激和慢性抗抑郁药物治疗的机制,
重点是促肾上腺皮质激素释放激素在
情感障碍的病理生理学 其他研究检查CNS
由滥用药物引起的适应性变化,如大麻和可卡因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M HERKENHAM其他文献
M HERKENHAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M HERKENHAM', 18)}}的其他基金
相似海外基金
Stratification of depression based on lysophospholipid metabolic disorders and innovative development of novel antidepressants
基于溶血磷脂代谢紊乱的抑郁症分层及新型抗抑郁药的创新开发
- 批准号:
23H02839 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
The role of antidepressants in central and peripheral myeloid HIV persistence and inflammation
抗抑郁药在中枢和外周髓系 HIV 持续存在和炎症中的作用
- 批准号:
10762810 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Concomitant use of antidepressants and oral antidiabetic drugs and the risk of hypoglycemia
抗抑郁药和口服抗糖尿病药的同时使用和低血糖的风险
- 批准号:
10679095 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Concomitant use of antidepressants and oral antidiabetic drugs and the risk of hypoglycemia
抗抑郁药和口服抗糖尿病药的同时使用和低血糖的风险
- 批准号:
10526807 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Leveraging Rapid-Acting Antidepressants for Personalized Response
利用速效抗抑郁药进行个性化治疗
- 批准号:
10387133 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Leveraging Rapid-Acting Antidepressants for Personalized Response
利用速效抗抑郁药进行个性化治疗
- 批准号:
10490846 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Leveraging Rapid-Acting Antidepressants for Personalized Response
利用速效抗抑郁药进行个性化反应
- 批准号:
10687872 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)
怀孕期间停用抗抑郁药后复发的风险(R-DAP 研究)
- 批准号:
10569044 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Do antidepressants promote the wound healing of the diabetes?
抗抑郁药能促进糖尿病伤口愈合吗?
- 批准号:
20K09860 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)
怀孕期间停用抗抑郁药后复发的风险(R-DAP 研究)
- 批准号:
10117285 - 财政年份:2020
- 资助金额:
-- - 项目类别: